Femoral Nerve Block vs Peri-capsular Nerve Group Block for Hip Fracture Analgesia

Comparison of Femoral Nerve Block Versus Peri-capsular Nerve Group Block for Analgesia During Positioning for Spinal Anesthesia in Patients With Hip Fracture

The purpose of the study is to compare the analgesic efficacy of femoral nerve block and peri-capsular nerve group block administered before spinal anesthesia for positioning to spinal anaesthesia in patients undergoing surgery for hip fracture and to evaluate the efficacy for postoperative analgesia

Study Overview

• Status: Completed
• Conditions: Analgesia; Hip Fractures; Spinal Anesthesia
• Intervention / Treatment: Other: femoral nerve block; Other: peri-capsular nerve group block

Detailed Description

Spinal anesthesia is commonly used in patients undergoing hip fracture surgery. However the procedure of patient positioning to perform a spinal block is painful and may require the administration of IV analgesics or some regional anesthesia techniques such as femoral nerve block, fascia-iliaca compartment block, peri-capsular nerve group block. At the study, the investigators aimed to compare analgesic efficacy of femoral nerve block and peri-capsular nerve group block administered before spinal anesthesia for positioning to spinal anaesthesia in patients undergoing surgery for hip fracture and to evaluate the efficacy for postoperative analgesia.

• Study Type: Interventional
• Enrollment (Actual): 52
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Turkey
  • Antalya, Turkey
    • Antalya Training and Research Hospital

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 85 years (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• patients with hip fracture scheduled for surgery under spinal anesthesia.

Exclusion Criteria:

• hemorrhagic diathesis,
• peripheral neuropathy,
• allergy to local anesthetics,
• mental disorders,
• use of analgesics for 8 h before the performance of spinal block

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Other
• Allocation: Non-Randomized
• Interventional Model: Parallel Assignment
• Masking: Double

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Other: Femoral nerve block group; Thirty minutes before the placement of spinal block, patients will be receive a femoral nerve block with Bupivacaine.	Other: femoral nerve block; Patients will be performed a femoral nerve block using bupivacaine thirty minutes before the performing of spinal block.
Other: Peri-capsular nerve group block group; Thirty minutes before the placement of spinal block, patients will be receive a peri-capsular nerve group block with Bupivacaine.	Other: peri-capsular nerve group block; Patients will be performed a peri-capsular nerve group block using bupivacaine thirty minutes before the performing of spinal block.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Rate of pain scores assessed by Numerical rating Score Scale during positioning for spinal anesthesia	Pain scores will be assessed by Numerical Rating Scale (NRS) scores (from 0=no pain to 10=maximum possible pain).	30 minutes

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Rate of pain scores at rest	Pain scores will be assessed by Numerical Rating Scale (NRS) scores from 0 (no pain) to 10 (maximum possible pain) at rest before and 30 min after the block performance.	30 min
Rate of pain scores on passive limb lifting	Pain scores will be assessed by Numerical Rating Scale (NRS) scores from 0 (no pain) to 10 (maximum possible pain) on passive limb lifting before and 30 min after the block performance.	30 min
rate of postoperative pain scores	Pain scores will be assessed by Numerical Rating Scale (NRS) scores from 0 (no pain) to 10 (maximum possible pain).at 6, 12, 24 hours postoperatively.	24 hours
Amount of postoperative analgesic consumption	Postoperative analgesic consumption will be recorded for postoperative 24 hours	24 hours

Collaborators and Investigators

• Sponsor: Antalya Training and Research Hospital

Study record dates

Study Major Dates

• Study Start (Actual): July 6, 2022
• Primary Completion (Actual): November 7, 2022
• Study Completion (Actual): December 19, 2022

Study Registration Dates

• First Submitted: June 20, 2022
• First Submitted That Met QC Criteria: July 1, 2022
• First Posted (Actual): July 6, 2022

Study Record Updates

• Last Update Posted (Actual): March 13, 2023
• Last Update Submitted That Met QC Criteria: March 9, 2023
• Last Verified: June 1, 2022

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Wounds and Injuries; Leg Injuries; Femoral Fractures; Hip Injuries; Fractures, Bone; Hip Fractures
• Other Study ID Numbers: safa1

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No